Health
Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine – News-Medical.net
A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha)…
The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led the scientific community and pharmaceutical industry to focus on the development of vaccines to combat the health…
Continue Reading
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News20 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Noosa News23 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops
-
Business7 hours agoFord CEO makes stunning prediction about artificial intelligence